The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -60.94%.However, over the last six months, we can see a stronger performance of -30.54%. Over the last 30 days, the price of MGX has leaped by -27.32%. And in the last five days, it has fallen by -4.73%.
Metagenomi Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $10.94 on 04/05/24 and the lowest value was $1.25 on 04/04/25.
52-week price history of MGX Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Metagenomi Inc’s current trading price is -87.11% away from its 52-week high, while its distance from the 52-week low is 13.23%. The stock’s price range during this period has varied between$1.25 and $10.94. The Metagenomi Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.59 million for the day, a figure considerably lower than their average daily volume of 0.91 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Metagenomi Inc (MGX) has experienced a quarterly decline of -62.80% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 52.71M and boasts a workforce of 202 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.4660, with a change in price of -0.6300. Similarly, Metagenomi Inc recorded 1,655,110 in trading volume during the last 100 days, posting a change of -30.88%.
MGX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for MGX stands at 0.19. Similarly, the long-term debt-to-equity ratio is also 0.17.
MGX Stock Stochastic Average
Metagenomi Inc’s raw stochastic average for the past 50 days is presently 9.78%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 20.81%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 9.17% and 5.52%, respectively.
